Patent classifications
A01N43/90
Inhibitors of the shikimate pathway
The present invention relates to novel inhibitors of the shikimate pathway (shikimic acid pathway), pharmaceutical compositions comprising these novel inhibitors, methods for the production of the inhibitors and their use as antibiotics and herbicides.
Multi-component, soil-applied, pesticidal compositions
The present disclosure describes compositions and methods for agricultural production. The formulations described herein enable to combine several active compounds, and are compatible with fertilizers, in particular, liquid fertilizers.
Multi-component, soil-applied, pesticidal compositions
The present disclosure describes compositions and methods for agricultural production. The formulations described herein enable to combine several active compounds, and are compatible with fertilizers, in particular, liquid fertilizers.
Multi-component, soil-applied, pesticidal compositions
The present disclosure describes compositions and methods for agricultural production. The formulations described herein enable to combine several active compounds, and are compatible with fertilizers, in particular, liquid fertilizers.
PHYTOSANITARY COMPOSITION FOR USE AS A BACTERICIDE
The present invention relates to a phytosanitary composition with bactericidal effect comprising eucalyptus oil, at least one diluent, at least one surfactant and at least one antioxidant, and the use of such composition as a bactericide in the protection of plants.
PHYTOSANITARY COMPOSITION FOR USE AS A BACTERICIDE
The present invention relates to a phytosanitary composition with bactericidal effect comprising eucalyptus oil, at least one diluent, at least one surfactant and at least one antioxidant, and the use of such composition as a bactericide in the protection of plants.
EFFECTS OF NF-kB SIGNALING INHIBITORS ON BED BUG RESISTANCE TO ORALLY PROVISIONED ENTOMOPATHOGENIC BACTERIA
Treatment compositions for controlling bed bugs and methods of use, including reducing bed bug resistance to a biological control agent are disclosed. The treatment compositions can include both a NF-kB signaling inhibitor and biological control agent, such as, an entomopathogenic bacteria, to improve the treatment composition efficacy against bed bugs. Provisioning of a small molecule inhibitor of NF-kB signaling can increase the rate of bed bug mortality during infection with a bacterial entomopathogen. Increased mortality can be independent of direct effects of the inhibitor on bacterial growth and can be instead the result of a reduced ability of bed bugs to clear the infection when treated with the inhibitor.
EFFECTS OF NF-kB SIGNALING INHIBITORS ON BED BUG RESISTANCE TO ORALLY PROVISIONED ENTOMOPATHOGENIC BACTERIA
Treatment compositions for controlling bed bugs and methods of use, including reducing bed bug resistance to a biological control agent are disclosed. The treatment compositions can include both a NF-kB signaling inhibitor and biological control agent, such as, an entomopathogenic bacteria, to improve the treatment composition efficacy against bed bugs. Provisioning of a small molecule inhibitor of NF-kB signaling can increase the rate of bed bug mortality during infection with a bacterial entomopathogen. Increased mortality can be independent of direct effects of the inhibitor on bacterial growth and can be instead the result of a reduced ability of bed bugs to clear the infection when treated with the inhibitor.
Degradation agent using autophagic mechanism of damaged mitochondria
Provided is a degrader for injured mitochondria based on an autophagy mechanism, the degrader including a compound or a salt thereof, the compound containing a ligand capable of binding to or accumulating in mitochondria and a substituent represented by the following general formula (1): ##STR00001##
where R.sup.1, R.sup.2, and R.sup.3 are identical to or different from each other, and each represent a hydrogen atom or the like.
MOLECULAR COMPLEXES
The present invention relates to a crystalline molecular complex comprising: (a) the herbicide pinoxaden, and (b) a second herbicide selected from the group consisting of fluroxypyr, 2,4-dichlorophenoxyacetic acid, 2-methyl-4-chlorophenoxyacetic acid and 3,6-dichloro-2-methoxybenzoic acid.
The invention also relates to processes for the preparation of the crystalline molecular complex, a herbicidal composition comprising the crystalline molecular complex, and use of the herbicidal composition.